Inventor
MORRIS MARK
US32 patents
⚠️ This page may combine multiple inventors who share the name “MORRIS MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HONEYWELL INT INC
10 patentsUS11525401B2Dec 13, 2022
Impingement baffle for gas turbine engine
HONEYWELL INT INC2 citations72
US11897065B2Feb 13, 2024
Composite turbine disc rotor for turbomachine
HONEYWELL INT INC1 citations59
US11846203B1Dec 19, 2023
Turbine nozzle with dust tolerant impingement cooling
HONEYWELL INT INC1 citations59
US11230929B2Jan 25, 2022
Turbine component with dust tolerant cooling system
HONEYWELL INT INC1 citations56
US12421906B2Sep 23, 2025
Gas turbine engines and methods for reducing spool thrust in a combustor section thereof
HONEYWELL INT INC0 citations47
US12345173B2Jul 1, 2025
Gas turbine engines and methods for reducing spool thrust in a turbine section thereof
HONEYWELL INT INC0 citations47
US11421541B2Aug 23, 2022
Turbine nozzle with compliant joint
HONEYWELL INT INC0 citations45
US12467368B1Nov 11, 2025
Turbine blade double tip flag cooling system
HONEYWELL INT INC0 citations42
US11156113B2Oct 26, 2021
Turbine nozzle compliant joints and additive methods of manufacturing the same
HONEYWELL INT INC0 citations36
US11299993B2Apr 12, 2022
Rotor assembly for in-machine grinding of shroud member and methods of using the same
HONEYWELL INT INC0 citations35
ELYSIUM HEALTH INC
6 patentsUS12043616B2Jul 23, 2024
Crystalline forms of nicotinamide riboside chloride
ELYSIUM HEALTH INC2 citations68
US11414407B2Aug 16, 2022
Crystalline forms of nicotinamide riboside chloride
ELYSIUM HEALTH INC2 citations68
US11629163B2Apr 18, 2023
Methods of synthesizing nicotinamide riboside
ELYSIUM HEALTH INC0 citations56
US11129843B2Sep 28, 2021
Treating and preventing kidney damage
ELYSIUM HEALTH INC0 citations56
US12128060B2Oct 29, 2024
Nicotinamide riboside for use in treating or preventing liver damage
ELYSIUM HEALTH INC0 citations55
US11389468B2Jul 19, 2022
Nicotinamide riboside for use in treating or preventing liver damage
ELYSIUM HEALTH INC1 citations55
CHROMADEX INC
4 patentsUS10183036B2Jan 22, 2019
Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as NAD+ increasing precursors
CHROMADEX INC6 citations68
US12433908B2Oct 7, 2025
Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development
CHROMADEX INC0 citations57
US11524022B2Dec 13, 2022
Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development
CHROMADEX INC0 citations57
US10857172B2Dec 8, 2020
Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development
CHROMADEX INC0 citations46